ARCHIVES

Sentinel Lymph Node Excision Has No Impact on Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Edelson to Direct Yale Cancer Center (12-page issue).

May 30, 2003

Funding Opportunities: NCI Seeks SBIR Applicants For Research On Detection Assays

July 3, 1998

Rauscher For Cancer Program

May 20, 1977

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

November 18, 2011

Prevention Task Force Unable To Reach Consensus On New Division, Tries To Avoid More Disruption

July 6, 1979

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014